This federal contract award was issued to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, headquartered in Naples, Florida. The contract, valued at $1,100.88, is a Delivery Order contract with a Fixed Price with Economic Price Adjustment pricing type, awarded by the Defense Logistics Agency's Medical Supply Chain. The contract is for the supply of APOLLORFSJ50 ASIPRATING ABLATOR 50 products, which are likely specialized orthopedic medical devices or implants. The award does not have a set-aside designation, indicating Arthrex's strong competitive position in the open federal market.
Arthrex also holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, valued at $471,048,172.66 and running from June 11, 2024, to September 1, 2029. This IDC allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders, including surgical implants, arthroscopic instruments, joint replacement technologies, and specialized instrument systems. To date, Arthrex has received over $550,000 in delivery orders under this IDC, demonstrating its ability to efficiently support government healthcare systems with specialized orthopedic solutions tailored to the needs of veterans and military personnel.
Generated 4/1/25, 5:42 PM